GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glow LifeTech Corp (XCNQ:GLOW) » Definitions » Capex-to-Operating-Income

Glow LifeTech (XCNQ:GLOW) Capex-to-Operating-Income : 0.00 (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Glow LifeTech Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Glow LifeTech's Capital Expenditure for the three months ended in Sep. 2023 was C$0.00 Mil. Its Operating Income for the three months ended in Sep. 2023 was C$-0.37 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Glow LifeTech Capex-to-Operating-Income Historical Data

The historical data trend for Glow LifeTech's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glow LifeTech Capex-to-Operating-Income Chart

Glow LifeTech Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Capex-to-Operating-Income
- - - -

Glow LifeTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Glow LifeTech's Capex-to-Operating-Income

For the Biotechnology subindustry, Glow LifeTech's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glow LifeTech's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glow LifeTech's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Glow LifeTech's Capex-to-Operating-Income falls into.



Glow LifeTech Capex-to-Operating-Income Calculation

Glow LifeTech's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.062) / -2.296
=N/A

Glow LifeTech's Capex-to-Operating-Income for the quarter that ended in Sep. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.365
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glow LifeTech  (XCNQ:GLOW) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Glow LifeTech Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Glow LifeTech's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Glow LifeTech (XCNQ:GLOW) Business Description

Traded in Other Exchanges
Address
65 International Boulevard, Suite 206, Etobicoke, ON, CAN, M9W 6L9
Glow LifeTech Corp is a biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption, and effectiveness. Its plant-based MyCell Technology delivery system transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.
Executives
Daniel Proska Director

Glow LifeTech (XCNQ:GLOW) Headlines

No Headlines